Brii Biosciences Doses First Patient With mRNA Cancer Vaccine BRII-5395
Brii Biosciences disclosed that the first participant was dosed on August 12 with BRII-5395, an internally discovered mRNA therapeutic cancer vaccine, in an early Phase I study for advanced hepatitis B virus-related hepatocellular carcinoma….
